BioCentury
ARTICLE | Financial News

Puma jumps on neratinib 'graduation'

December 6, 2013 1:54 AM UTC

Puma Biotechnology Inc. (NYSE:PBYI) jumped $31.49 (68%) to $77.70 on Thursday after reporting late Wednesday that a regimen containing the company's neratinib "graduated" from the open-label I-SPY 2 t...